|
|
|
Insider
Information: |
Pollard-Knight Denise |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
869,152 |
|
Indirect Shares
|
1,466,923 |
|
|
Direct
Value |
$4,207,666 |
|
|
Indirect Value
|
$51,454,485 |
|
|
Total
Shares |
2,336,075 |
|
|
Total
Value |
$55,662,151 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
0.0%
|
49.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Idenix Pharmaceuticals Inc |
IDIX |
Director |
2004-07-27 |
0 |
2005-11-14 |
301,476 |
Premium* |
|
Albireo Pharma Inc |
ALBO |
Director, 10% Owner |
2016-11-03 |
0 |
2016-11-03 |
1,165,447 |
Premium* |
|
Elanco Animal Health Inc |
ELAN |
|
2023-11-30 |
60,231 |
2019-04-11 |
0 |
Premium* |
|
Mereo Biopharma Group plc |
MREO |
|
2024-09-13 |
808,921 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALBO |
Albireo Pharma Inc |
Director |
|
2016-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,165,447 |
1,165,447 |
0 |
- |
|
ELAN |
Elanco Animal Health Inc |
Director |
|
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
2,783 |
0 |
- |
|
ELAN |
Elanco Animal Health Inc |
Director |
|
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,233 |
8,016 |
0 |
- |
|
ELAN |
Elanco Animal Health Inc |
Director |
|
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
13,901 |
0 |
- |
|
ELAN |
Elanco Animal Health Inc |
|
|
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,649 |
39,857 |
0 |
- |
|
ELAN |
Elanco Animal Health Inc |
|
|
2023-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,374 |
60,231 |
0 |
- |
|
IDIX |
Idenix Pharmaceuticals In... |
Director |
|
2004-07-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,031,252 |
|
- |
|
IDIX |
Idenix Pharmaceuticals In... |
Director |
|
2004-07-27 |
4 |
D |
$14.00 |
$1,403,892 |
I/I |
(100,278) |
930,974 |
|
- |
|
IDIX |
Idenix Pharmaceuticals In... |
Director |
|
2005-11-14 |
4 |
S |
$20.61 |
$12,973,954 |
I/I |
(629,498) |
301,476 |
|
- |
|
MREO |
Mereo Biopharma Group plc |
Chief Executive OfficerOfficer |
|
2024-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
560,413 |
|
% |
|
MREO |
Mereo Biopharma Group plc |
Chief Executive Officer |
|
2024-06-25 |
4 |
S |
$3.69 |
$150,386 |
D/D |
(40,712) |
801,791 |
0 |
% |
|
MREO |
Mereo Biopharma Group plc |
Chief Executive Officer |
|
2024-06-26 |
4 |
S |
$3.39 |
$313,101 |
D/D |
(92,273) |
709,518 |
0 |
% |
|
MREO |
Mereo Biopharma Group plc |
Chief Executive Officer |
|
2024-09-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
188,060 |
897,578 |
0 |
- |
|
MREO |
Mereo Biopharma Group plc |
Chief Executive Officer |
|
2024-09-12 |
4 |
S |
$4.47 |
$127,968 |
D/D |
(28,611) |
868,967 |
0 |
% |
|
MREO |
Mereo Biopharma Group plc |
Chief Executive Officer |
|
2024-09-13 |
4 |
S |
$4.22 |
$253,454 |
D/D |
(60,046) |
808,921 |
0 |
% |
|
15 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|